Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|June 20, 2022
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint BlockadeShubhra Singh, Jason Roszik, Neeraj Saini, et al.
Frontiers in Microbiology|November 30, 2020
Prokaryotic and Fungal Characterization of the Facilities Used to Assemble, Test, and Launch the OSIRIS-REx SpacecraftAaron B Regberg, Christian L Castro, Harold C Connolly, et al.
British Journal of Haematology|March 29, 2019
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trialMelody R Becnel, Loretta J Nastoupil, Felipe Samaniego, et al.
Cell Metabolism|January 6, 2021
Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in MyelomaZongwei Li, Huan Liu, Jin He, et al.
Annals of Hematology|March 25, 2017
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myelomaMuhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2013
Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigenSoung-Chul Cha, Hong Qin, Shibichakravarthy Kannan, et al.
Nature Medicine|March 5, 2013
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletionYared Hailemichael, Zhimin Dai, Nina Jaffarzad, et al.
Cancer|June 29, 2016
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphomaDai Chihara, Jason R Westin, Yasuhiro Oki, et al.
Plos One|March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphomaDai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
Pageof 12